Lifeway Foods Inc is engaged in manufacturing probiotic, cultured, functional dairy health food products. Its primary product is drinkable kefir, which is a cultured dairy product. Its product categories are Drinkable Kefir, which is the key revenue-driving product, European-style soft cheeses, Cream, ProBugs, Frozen Kefir, and Other dairy. The company manufactures and markets products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers. It sells the products through a direct sales force, brokers, and distributors.
Last trade$18.09
Day change+$0.03 (+0.17%)
Day range$17.44 – $18.37
Volume87,364
Market cap$273M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$272.86M
Price / earnings
35.89×
Price / book
3.19×
Price / sales
1.08×
EV / sales
1.15×
EV / EBITDA
17.94×
Profitability
Earnings per share
$0.50
Return on assets
5.73%
Return on equity
8.9%
Dividend yield
0%
Liquidity and leverage
Debt / equity
0.28×
Current ratio
2.32×
Quick ratio
1.64×
Cash ratio
0.35×
Cash flow
Price / cash flow
52.43×
Price / free cash flow
—
Free cash flow
-$35.24M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for LWAY, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Revenue
$67.8M
$66.89M
$63.01M
$55.36M
$57.14M
$53.9M
$46.09M
$46.93M
Cost of revenue
$55.63M
$53.87M
$45.66M
$42.55M
$40.74M
$38.5M
$35.06M
$37.12M
Gross profit
$12.16M
$13.03M
$17.35M
$12.82M
$16.41M
$15.4M
$11.04M
$9.82M
Selling, general and administrative
$10.94M
$12.29M
$10.89M
$11.47M
$11.23M
$9.47M
$9.33M
$11.05M
Research and development
$0
$0
$0
$0
$0
$0
$0
$0
Total operating expenses
$11.08M
$12.43M
$11.03M
$9.05M
$11.37M
$9.61M
$9.46M
$9.1M
Operating income
$1.09M
$600K
$6.33M
$3.76M
$5.04M
$5.8M
$1.57M
$713K
Interest expense
-$340K
-$215K
-$68K
-$21K
-$21K
-$21K
-$14K
-$3K
Income before taxes
$765K
$407K
$6.26M
$3.72M
$5.09M
$5.91M
$4.97M
$776K
Income taxes
$505K
$280K
$1.58M
$1.18M
$1.56M
$1.66M
$1.43M
$936K
Net income
$260K
$127K
$4.67M
$2.54M
$3.53M
$4.25M
$3.54M
-$160K
Net income attributable to common shareholders
$260K
$127K
$4.67M
$2.54M
$3.53M
$4.25M
$3.54M
-$160K
EBITDA
$2.25M
$1.74M
$7.38M
$4.79M
$6.09M
$6.76M
$2.51M
$1.61M
Basic earnings per share
$0.02
$0.01
$0.31
$0.17
$0.23
$0.28
$0.23
-$0.01
Diluted earnings per share
$0.02
$0.01
$0.30
$0.16
$0.23
$0.28
$0.23
-$0.01
Recent news
Company coverage with links to the original publishers.
Lifeway Foods reported record Q3 2026 net sales of $67.8 million but faces margin pressure from elevated milk costs (gross margin at 18%). The company is doubling production capacity at its Waukesha facility by 2027 to meet demand and plans price increases to recover margins toward historical 25%+ levels. Growing GLP-1 adoption and consumer interest in gut health are driving retail shelf expansion.
Edward Smolyansky, largest shareholder and former COO of Lifeway Foods, criticizes the Board's governance, stating the poison pill was only terminated after ISS recommended voting against all directors. He highlights a pattern of reactive governance, the reversal of a board refresh process, and calls for shareholders to vote against incumbent directors at the June 17 Annual Meeting to register dissatisfaction with the Board's conduct.
The Law Offices of Frank R. Cruz is investigating potential claims against Lifeway Foods' board of directors for alleged breach of fiduciary duties to shareholders and gross mismanagement. The investigation targets shareholders who held shares before September 2025.
Law firm investigating potential breach of fiduciary duties by Lifeway Foods' board of directors, inviting shareholders who purchased shares before September 2025 to discuss potential claims.
Edward Smolyansky, a 10% owner of Lifeway Foods, sold 16,357 shares worth $435,551 on September 25, as disclosed in an SEC filing. The company continues to focus on manufacturing probiotic and cultured dairy products.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
Ex-dividend
Amount / share
Pay date
Type
May 29, 2013
$0.08
Jun 28, 2013
recurring
May 25, 2012
$0.07
Jun 29, 2012
recurring
Stock splits
Historical share-structure events and their execution dates.